Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KCNA3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | DCST1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ODF2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | DLX1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SSBP4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | HSD17B11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C2CD4A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | MEX3C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CD33 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |